Fi3 Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Buy
15,597
+415
+3% +$421K 4.14% 5
2025
Q4
$16.3M Buy
15,182
+264
+2% +$252K 4.99% 5
2025
Q3
$11.4M Buy
14,918
+196
+1% +$146K 3.85% 5
2025
Q2
$11.5M Sell
14,722
-297
-2% -$231K 4.14% 5
2025
Q1
$12.4M Buy
15,019
+102
+0.7% +$84.9K 5.04% 5
2024
Q4
$11.5M Buy
14,917
+33
+0.2% +$27.3K 4.31% 5
2024
Q3
$13.2M Buy
14,884
+22
+0.1% +$19.8K 5.24% 5
2024
Q2
$13.5M Buy
14,862
+151
+1% +$121K 5.92% 5
2024
Q1
$10.8M Sell
14,711
-118
-0.8% -$84K 4.97% 6
2023
Q4
$8.64M Buy
14,829
+31
+0.2% +$18.1K 4.12% 6
2023
Q3
$7.95M Buy
14,798
+127
+0.9% +$65.4K 4.27% 6
2023
Q2
$6.88M Buy
14,671
+23
+0.2% +$9.65K 3.6% 9
2023
Q1
$5.03M Sell
14,648
-70
-0.5% -$23.6K 2.68% 9
2022
Q4
$5.38M Buy
14,718
+48
+0.3% +$17K 3.08% 8
2022
Q3
$4.74M Sell
14,670
-141
-1% -$44.7K 4.32% 9
2022
Q2
$4.78M Buy
14,811
+87
+0.6% +$26.1K 3.95% 8
2022
Q1
$4.22M Sell
14,724
-15
-0.1% -$3.86K 3.28% 8
2021
Q4
$4.07M Buy
14,739
+175
+1% +$44.4K 2.66% 10
2021
Q3
$3.37M Sell
14,564
-188
-1% -$46.4K 2.23% 11
2021
Q2
$3.78M Sell
14,752
-5,904
-29% -$1.19M 2.59% 11
2021
Q1
$3.86M Buy
+20,656
New +$4.04M 3.32% 11

Other funds holding LLY

Fi3 Financial Advisors's LLY Position: Q1 2026 in Review

Fi3 Financial Advisors increased its Eli Lilly (LLY) stake by 2.7% in Q1 2026, buying an estimated $421K and bringing the position to 15,597 shares worth $14.3M. The position accounts for 4.14% of the portfolio, ranked #5.

Fi3 Financial Advisors first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $16.3M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fi3 Financial Advisors held 15,597 shares of Eli Lilly worth $14.3M as of Q1 2026.
  • Fi3 Financial Advisors bought 415 Eli Lilly shares in Q1 2026, an estimated $421K.
  • Eli Lilly made up 4.14% of Fi3 Financial Advisors's portfolio in Q1 2026, its #5 holding.
  • Fi3 Financial Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
  • Fi3 Financial Advisors's Eli Lilly position peaked at $16.3M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fi3 Financial Advisors's 13F filing for Q1 2026, filed 7 May 2026.